The most common question about our unicorn coverage is whether a billion-dollar valuation actually tells readers anything meaningful about a company's underlying health.
Why readers are right to be skeptical
Valuation reflects what investors are willing to pay for a stake in a company, which depends on future expectations as much as current fundamentals, and can diverge significantly from a company's actual operational strength.
Our actual approach to unicorn coverage
We try to pair valuation figures with whatever operational context is available - revenue, headcount, actual usage - to give readers a fuller picture than the valuation number alone provides.
Why we're honest when that context isn't available
Many unicorn companies disclose little beyond the valuation itself, and in those cases we're explicit that the valuation is the primary thing we can confirm, rather than implying a fuller picture we don't actually have.
Why this honesty matters
We think valuation-only coverage, presented without acknowledging its limits, risks readers treating a number as more informative than it actually is on its own.